04:55 PM EDT, 09/17/2025 (MT Newswires) -- Eben Tessari, COO, on September 15, 2025, sold 16,400 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $597,976. Following the Form 4 filing with the SEC, Tessari has control over a total of 34,552 Class A ordinary shares of the company, with 34,552 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000186789925000003/xslF345X05/form4-09172025_080944.xml